Case Study: Myriad Genetics achieves revenue cycle management excellence with KPMG Connected Enterprise

Myriad Genetics boosts cash collections by $35 million with KPMG

Myriad Genetics, a leading genetic testing and precision medicine company, faced challenges in its revenue cycle management (RCM) that threatened operational excellence and the patient experience. To refine its RCM, improve access to care, and enhance its bottom line, Myriad Genetics chose to partner with vendor KPMG and leverage its KPMG Connected Enterprise framework.

KPMG implemented a solution using its Connected Enterprise approach, which included new dashboards, patient-centric workflows, and technology enhancements. This transformation led to significant results, including $35 million in increased cash collections, a 15% rise in approved payer authorizations, and a 15-20% increase in individual contributor productivity for Myriad Genetics.

Myriad Genetics